Longitudinal analysis of immune profiling of COVID-19 finds elevated plasma levels of IL-17A and IL-22 along with increased IL-17 secretion by CD4+ T cells in severe patients, indicative of promotive effects of Th17 cells in COVID-19 progression (22). This evidence concerns the gene IL17A and COVID-19.